| Literature DB >> 31793429 |
A P Fontes-Sousa1, A C Silvestre-Ferreira2,3, E Carretón4, J Esteves-Guimarães5, C Maia-Rocha6, P Oliveira7, L Lobo8,9,10, R Morchón11, F Araújo6,12, F Simón11, J A Montoya-Alonso4.
Abstract
Dirofilariosis caused by Dirofilaria immitis (heartworm) is a zoonosis, considered an endemic disease of dogs and cats in several countries of Western Europe, including Portugal. This study assesses the levels of D. immitis exposure in humans from Northern Portugal, to which end, 668 inhabitants of several districts belonging to two different climate areas (Csa: Bragança, Vila Real and Csb: Aveiro, Braga, Porto, Viseu) were tested for anti-D. immitis and anti-Wolbachia surface proteins (WSP) antibodies. The overall prevalence of seropositivity to both anti-D. immitis and WSP antibodies was 6.1%, which demonstrated the risk of infection with D. immitis in humans living in Northern Portugal. This study, carried out in a Western European country, contributes to the characterisation of the risk of infection with D. immitis among human population in this region of the continent. From a One Health point of view, the results of the current work also support the close relationship between dogs and people as a risk factor for human infection.Entities:
Keywords: Dirofilaria immitis; Portugal; Wolbachia pipientis; human; seroepidemiologic study
Year: 2019 PMID: 31793429 PMCID: PMC6805740 DOI: 10.1017/S0950268819001687
Source DB: PubMed Journal: Epidemiol Infect ISSN: 0950-2688 Impact factor: 2.451
Seroprevalence of human dirofilariasis in Northern Portugal, as defined by seropositivity for antibodies against both D. immitis and WSP
| Male | Female | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Positive | Positive | Positive | ||||||||||
| % | 95% CI | % | 95% CI | % | 95% CI | |||||||
| 333 | 21 | 6.3 | 4.2–9.5 | 335 | 20 | 6.0 | 3.9–9.0 | 668 | 41 | 6.1 | 4.6–8.2 | |
| Age (years) | ||||||||||||
| ⩽35 | 74 | 5 | 6.8 | 2.3–14.9 | 94 | 7 | 7.4 | 3.7–14.6 | 168 | 12 | 7.1 | 4.1–12.1 |
| 36–50 | 108 | 7 | 6.5 | 3.2–12.8 | 85 | 2 | 2.4 | 1.0–8.2 | 193 | 9 | 4.7 | 2.5–8.6 |
| 51–65 | 71 | 2 | 2.8 | 1.0–9.7 | 62 | 4 | 6.5 | 2.5–15.5 | 133 | 6 | 4.5 | 2.1–9.5 |
| ⩾66 | 80 | 7 | 8.8 | 4.3–17.0 | 94 | 7 | 7.4 | 3.7–14.6 | 174 | 14 | 8.0 | 4.9–13.1 |
| Study sites | ||||||||||||
| 137 | 11 | 8.0 | 4.5–13.8 | 172 | 10 | 5.8 | 3.2–10.4 | 309 | 21 | 6.8 | 4.5–10.2 | |
| Bragança | 9 | 1 | 11.1 | 2.0–43.5 | 17 | 0 | 0.0 | 0.0–18.4 | 26 | 1 | 3.9 | 1.0–18.9 |
| Vila Real | 128 | 10 | 7.8 | 4.3–13.8 | 155 | 10 | 6.5 | 3.5–11.5 | 283 | 20 | 7.1 | 4.6–10.7 |
| 196 | 10 | 5.1 | 2.8–9.1 | 163 | 10 | 6.1 | 3.4–10.9 | 359 | 20 | 5.6 | 3.6–8.5 | |
| Porto | 166 | 9 | 5.4 | 2.9–10.0 | 135 | 7 | 5.2 | 2.5–10.3 | 301 | 16 | 5.3 | 3.3–8.5 |
| Viseu | 20 | 0 | 0.0 | 0.0–16.1 | 24 | 3 | 12.5 | 4.3–31.0 | 44 | 3 | 6.8 | 2.4–18.2 |
| Braga | 4 | 0 | 0.0 | 0.0–49.0 | 2 | 0 | 0.0 | 0.0–65.8 | 6 | 0 | 0.0 | 0.0–39.0 |
| Aveiro | 6 | 1 | 16.7 | 3.0–56.4 | 2 | 0 | 0.0 | 0.0–65.8 | 8 | 1 | 12.5 | 2.2–47.1 |
Fig. 1.Map of Portugal showing the areas included in the current study and the distribution of the positive subjects vs. the total subjects evaluated per area.